tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage

Tonix Pharmaceuticals Holding Corp.

Sold short TNXP

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

test user

Sold <1% of TNXP

Sold all 890260862

Mike Pelech

Sold 25% of 890260862

Sold 20% of 890260862

New position in 890260862

Sold 18% of 890260862

Bought 100% more 890260862

Bought 50% more TNXP

Bought 100% more TNXP

Bought 1% more TNXP

Six Montahue

Sold 2% of TNXP

Bought <1% more TNXP

Bought 9% more TNXP